ID: ALA609516

Max Phase: Preclinical

Molecular Formula: C15H25N4O9P

Molecular Weight: 436.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NP(=O)(O)OC[C@H]1OC(n2ccc(N)nc2=O)[C@H](O)[C@@H]1O)C(=O)O

Standard InChI:  InChI=1S/C15H25N4O9P/c1-7(2)5-8(14(22)23)18-29(25,26)27-6-9-11(20)12(21)13(28-9)19-4-3-10(16)17-15(19)24/h3-4,7-9,11-13,20-21H,5-6H2,1-2H3,(H,22,23)(H2,16,17,24)(H2,18,25,26)/t8-,9+,11+,12+,13?/m0/s1

Standard InChI Key:  WOELGXZWKAHHFH-NDOBCPHVSA-N

Associated Targets(non-human)

CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 436.36Molecular Weight (Monoisotopic): 436.1359AlogP: -1.35#Rotatable Bonds: 9
Polar Surface Area: 206.46Molecular Species: ACIDHBA: 10HBD: 6
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.45CX Basic pKa: CX LogP: -1.97CX LogD: -7.62
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.25Np Likeness Score: 1.15

References

1. Whalen LJ, McEvoy KA, Halcomb RL..  (2003)  Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.,  13  (2): [PMID:12482445] [10.1016/s0960-894x(02)00735-7]

Source